ONCOSEC MED INC - COM NEW (ONCS)

CUSIP: 68234L207

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM NEW
Total 13F shares
893,385
Share change
+847
Total reported value
$4,600,000
Price per share
$5.14
Number of holders
17
Value change
-$19,488
Number of buys
13
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 68234L207?
CUSIP 68234L207 identifies ONCS - ONCOSEC MED INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCOSEC MED INC - COM NEW (ONCS) as of Q3 2015

As of 30 Sep 2015, ONCOSEC MED INC - COM NEW (ONCS) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 893,385 shares. The largest 10 holders included VANGUARD GROUP INC, SABBY MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Fund Advisors, NORTHERN TRUST CORP, Bank of New York Mellon Corp, EDMOND DE ROTHSCHILD (SUISSE) S.A., EDMOND DE ROTHSCHILD HOLDING S.A., BlackRock Institutional Trust Company, N.A., and Mount Lucas Management LP. This page lists 17 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.